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ABSTRACT A stopped-flow spectrofluorometer equipped with a rapid scanning emission monochromator was utilized to
monitor the binding of adriamycin to phospholipid liposomes. The latter process is evident as a decrease in fluorescence
emission from a trace amount of a pyrene-labeled phospholipid analog (PPDPG, 1-palmitoyl-2-[(6-pyren-1-yl)]decanoyl-sn-
glycero-3-phospho-rac-glycerol) used as a donor for resonance energy transfer to adriamycin. For zwitterionic 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) liposomes, fluorescence decay was slow, with a half-time t1/2 of 2 s. When
the mole fraction of the acidic phospholipid, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol (POPG), was increased
to XPG  0.04, the decay of fluorescence became double exponential, and an additional, significantly faster process with t1/2
in the range between 2 and 4 ms was observed. Subsequently, as XPG was increased further, the amplitude of the fast
process increased, whereas the slower process was attenuated, its t1/2 increasing to 20 s. Increasing [NaCl] above 50 mM
or [CaCl2] above 150 M abolished the fast component, thus confirming this interaction to be electrostatic. The critical
dependence of the fast component on XPG allows the use of this process to probe the organization of acidic phospholipids
in liposomes. This was demonstrated with 1,2-palmitoyl-sn-glycero-3-phosphocholine (DPPC) liposomes incorporating
PPDPG (XPPDPG  0.03), i.e., conditions where XPG in fluid bilayers is below the required threshold yielding the fast
component. In keeping with the presence of clusters of PPDPG, the fast component was observed for gel-state liposomes.
At 34°C (i.e., 6° below Tm), the slower fluorescence decay also appeared, and it was seen throughout the main phase
transition region as well as in the liquid-crystalline state. The fluorescence decay behavior at temperatures below, above, and
at the main phase transition temperature is interpreted in terms of thermal density fluctuations and an intermediate state
between gel and liquid-crystalline states being involved in the phospholipid main phase transition. This is the first observation
of a cluster constituted by acidic phospholipids controlling the membrane association of a drug.
INTRODUCTION
Lateral heterogeneity and domain formation in biomem-
branes are well established (for reviews see Knoll et al.,
1991; Rodgers and Glaser, 1991; Kinnunen, 1991; Gascard
et al., 1993; Tocanne et al., 1994; Welti and Glaser, 1994)
and have been shown to be of importance to the membrane
binding and function of proteins such as cytochrome c
(Vanderkooi et al., 1973; Mustonen et al., 1987) and gelso-
lin (Janmey and Chaponnier, 1995), in the coupling of
G-proteins to their receptors (Neubig, 1994), in the budding
of viruses from the plasma membrane (Luan and Glaser,
1994), and in the activation of pancreatic lipase by colipase
(Momsen et al., 1995). Considering the coupling between
dynamic order and function emphasized in the modern view
of biological membranes (see e.g., Kinnunen, 1991; Kin-
nunen and Mouritsen, 1994; Kinnunen et al., 1994; Mourit-
sen and Kinnunen, 1996), thorough understanding of the
mechanisms causing lateral organization of membranes is
clearly of fundamental importance. To this end, several
molecular-level mechanisms have by now been established
in model membranes, as follows.
Characteristically for liquid crystalline materials, phos-
pholipids can exist in several phases such as gel, liquid
crystalline, interdigitated, or inverted nonlamellar phases
(Kinnunen and Laggner, 1991). Both the coexistence of gel
and fluid (liquid crystalline) phases and fluid-fluid immis-
cibility have been demonstrated for binary alloys (e.g.,
Shimshick and McConnell, 1973; Wu and McConnell,
1975; Holopainen et al., 1997). Dehydration-induced phase
separation was predicted on theoretical grounds (Bryant and
Wolfe, 1989) and was recently verified for binary liquid
crystalline bilayers (Lehtonen and Kinnunen, 1995). There
is evidence of lateral heterogeneity in lipid membranes
being induced by alcohol (Rowe, 1987; Mou et al., 1994). In
binary membranes containing charged (anionic or cationic)
species, phase separation can be induced by Ca2 (Galla
and Sackmann, 1975; Eklund et al., 1988), polycations
(Hartmann et al., 1977; Eklund and Kinnunen, 1986), DNA
(Koˆiv et al., 1994), electric fields (Lee et al., 1994; Lee and
McConnell, 1995; So¨derlund et al., 1997), and pH (Tilcock
and Cullis, 1981). Likewise, several cationic peripheral
proteins induce the segregation of acidic phospholipids
(Kinnunen et al., 1994). In tertiary alloys the cationic am-
phiphile sphingosine seems to form microdomains with
phosphatidic acid (Mustonen et al., 1993). The mismatch
between the lengths of the hydrophobic membrane-span-
ning segments of integral membrane proteins and those of
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lipids was proposed as a mechanism causing ordering of
membranes (Mouritsen and Bloom, 1984). This principle
was recently confirmed experimentally for Escherichia coli
lactose permease (Lehtonen and Kinnunen, 1997) and bac-
teriorhodopsin (Dumas et al., 1997) reconstituted into lipo-
somes. Hydrophobic matching conditions have also been
shown to induce lipid microdomains in fluid, liquid crys-
talline phospholipid alloys (Lehtonen et al., 1996). Steric
elastic strain has been suggested to provide the driving force
for the formation of well-defined superlattices in liquid
crystalline liposomes (for brief reviews see Kinnunen,
1991; Kinnunen et al., 1993).
The biological significance of the rich scale of different
lipid phases and phase transitions has remained mostly
unknown. Phospholipid chain melting at the main transition
occurs via the growth of fluid lipid domains in a bulk
gel-state membrane. Accordingly, the main transition
readily involves dynamic ordering and lateral heterogeneity
in the membrane (Mouritsen, 1991, and references therein),
which further have profound effects on membrane proper-
ties and on lipid-protein interactions, for instance (for a brief
review see, e.g., Mouritsen and Kinnunen, 1996). To this
end, although dynamic lateral heterogeneity is indeed in-
herent to any two-dimensional melting process, it is still
extremely challenging to describe the relevant processes in
terms of molecular interactions (Jutila and Kinnunen, 1997).
Several drugs bearing a positive charge have been shown
to interact with acidic phospholipids. In this respect, per-
haps the best characterized is adriamycin (e.g., Karczmar
and Tritton, 1979; Goormaghtigh et al., 1980a; Henry et al.,
1985; de Wolf et al., 1991), a chemotherapeutic drug that is
highly soluble in water yet also effectively partitions into
membranes. Drug-lipid interactions are believed to be im-
portant to the cytotoxicity of adriamycin and may also
underlie its clinically most feared, dose-dependent side ef-
fect, cardiotoxicity, which involves impairment of mito-
chondrial function (e.g., Rosenoff et al., 1975; Solem et al.,
1996; Doroshow, 1991; Duarte-Karim et al., 1976; Goor-
maghtigh et al., 1980b, 1982, 1986; Huart et al., 1984;
Nicolay and de Kruijff, 1987). The mechanism of adriamy-
cin cytotoxicity appears to be the induction of apoptosis
(e.g., Skladanowski and Konopa, 1993; Ling et al., 1993;
Zaleskis et al., 1994; Anand et al., 1995; Mu¨ller et al.,
1997). In this regard, the activation of phospholipase A2 by
adriamycin demonstrated in vitro to result from drug-phos-
pholipid interaction could be relevant (Mustonen and Kin-
nunen, 1991).
Two types of binding have been suggested to be involved
in adriamycin-acidic phospholipid interactions (Karczmar
and Tritton, 1979; Henry et al., 1985). In the first mecha-
nism there is an electrostatic association of the amino sugar
moiety of the drug with the ionized phosphate of acidic
phospholipid, while the dihydroxyanthraquinone ring struc-
tures would remain outside the bilayer and may further
interact with each other by forming stacks (Goormaghtigh
and Ruys-schaert, 1984; Henry et al., 1985; Nicolay et al.,
1988). Interaction of the amino sugar with the ionized
phosphate is also central in the second mechanism, which
additionally involves intercalation of the dihydroxyanthra-
quinone moiety between the fatty acid chains of phospho-
lipids within the lipid membrane (Dupou-Ce´zanne et al.,
1989; Henry et al., 1985; Fiallo and Garnier-Suillerot,
1986). The above conclusions have been derived from
steady-state equilibrium studies (e.g., Karczmar and Tritton,
1979; Goormaghtigh et al., 1980b; Henry et al., 1985; de
Wolf et al., 1991).
To our knowledge, the binding of adriamycin to phos-
pholipids has not been assessed by stopped-flow techniques.
We report here on the dependence of the rate of the binding
of adriamycin to liposomes on their content of the acidic
phospholipids. Subsequently, we used the kinetics of drug-
membrane interaction to probe membrane lateral order in
the course of the main transition of a binary phospholipid
alloy.
MATERIALS AND METHODS
Materials
HEPES, EDTA, and adriamycin (doxorubicin) were from Sigma, and NaCl
and CaCl2 were from Merck (Merck, Darmstadt, Germany). 1-Palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphoglycerol (POPG) were from Avanti Polar Lipids
(Alabaster, AL). Pyrene-containing phospholipid analogs, 1-palmitoyl-2-
[(6-pyren-1-yl)]decanoyl-sn-glycero-3-phosphocholine (PPDPC) and
1-palmitoyl-2-[(6-pyren-1-yl)]decanoyl-sn-glycero-3-phosphoglycerol
(PPDPG), were obtained from K&V Bioware (Espoo, Finland). Dipalmi-
toylphosphatidylcholine (DPPC) was from Coatsome (Amagasaki, Hyogo,
Japan). The purity of the lipids was checked by thin-layer chromatography
on silicic acid-coated plates (Merck), using chloroform/methanol/water
(65:25:4, v/v) as a solvent. Examination of the plates after iodine staining
or, when appropriate, upon fluorescence illumination revealed no impuri-
ties. Lipid stock solutions were made in chloroform. Concentrations of the
nonfluorescent phospholipids were determined gravimetrically with a high-
precision electrobalance (Cahn Instruments, Cerritos, CA), and those of the
pyrene-containing phospholipid analogs were determined spectrophoto-
metrically, using the molar extinction coefficient   42,000 at 344 nm.
Adriamycin was dissolved in the buffer, and its concentration was deter-
mined spectrophotometrically, using   11,500 at 480 nm.
Preparation of liposomes
Lipids were mixed in the indicated molar ratios. Unless otherwise indi-
cated, the content of the fluorescent probe (PPDPC or PPDPG) was X 
0.03, which was chosen as a probe concentration to enhance signal-to-noise
ratio. In experiments on large unilamellar vesicles (LUVs) with XPG 
0.03, PPDPG (X  0.03) was preferred to assess more directly the corre-
lation between half-time of the fluorescence decay (t1/2) for the binding and
the distribution of the probe (representing phosphatidylglycerol, PG) in the
membrane. This does not affect the appearance of the fast component,
which for fluid membranes was evident only at XPG  0.04. The lipid
mixtures were evaporated to dryness under a stream of nitrogen and then
kept under reduced pressure for at least 2 h to remove traces of solvent. Dry
residues were hydrated in buffer for 30 min at 15°C above the gel 3
liquid crystalline transition temperature (Tm) of lipid used. Large unila-
mellar liposomes (diameter 80  25 nm; MacDonald et al., 1991) were
made by extruding the lipid dispersions 17 times through two Millipore
polycarbonate filters (average pore size 100 nm; Millipore, Bedford, MA),
using a LiposoFast (Avestin, Ottawa, Canada) small-volume homogenizer.
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Liposomes were stored in a refrigerator (4°C) and were used within 24 h
after hydration.
Stopped-flow fluorescence spectroscopy
Electronic energy is efficiently transferred from a fluorescent energy donor
to a suitable acceptor up to a distance of 60 Å, with the rate of the transfer
depending on the reciprocal of the sixth power of the average distance
between the donor and the acceptor. Furthermore, orientation of the donor
and acceptor relaxation and excitation dipoles and the magnitude of their
spectral overlap determine the efficiency of the energy transfer process
(Stryer, 1978). Adriamycin has a broad absorption peak centered at 480 nm
that overlaps the emission spectrum of pyrene (Mustonen and Kinnunen,
1991). With excitation at 344 nm and measurement of pyrene (donor)
emission in the 375–525 nm range, it is possible to measure the binding of
adriamycin (acceptor) to lipid membranes embedding pyrene containing a
phospholipid analog, e.g., PPDPC or PPDPG (Mustonen and Kinnunen,
1991, 1993; Koˆiv and Kinnunen, 1994); the membrane association of the
drug is readily evident as a decrease in pyrene emission intensity.
The binding of adriamycin to liposomes was measured using a stopped-
flow spectrofluorometer (Olis RSM 1000F; On-Line Instruments, Bogart,
GA) equipped with a rapid scanning monochromator and a water-cooled
450 W xenon lamp. Two pneumatically driven (gas pressure 7 bar) sy-
ringes were mounted in parallel to inject the reactants into the rapid-mixing
quartz glass fluorescence observation chamber (20-mm path length,
1.5-mm diameter). The temperature in the reaction chamber and in the
syringes was regulated by a computer-controlled circulating waterbath
(Neslab Instruments, Portsmouth, NH). The initial concentration of phos-
pholipid was 50 M and that of adriamycin 8 M, thus yielding the
corresponding final concentrations of 25 and 4 M in the mixing chamber.
An excitation wavelength of 344 nm was selected with a monochromator,
and the beam was passed through subsequent 6.12-mm and 3.16-mm slits.
A maximum of 1000 spectra/s was measured by passing the beam through
a 1.24-mm slit and a rotating spoke wheel. Fluorescence emission between
375 and 525 nm was recorded with a photomultiplier tube. Photomultiplier
output was digitized by a Pentium PC equipped with an A/D converter. The
fluorescence decays for each sample were monitored by using scanning
rates of 1000, 62, and 10 scans/s, with the respective collection times of
0.25, 5, and 96 s.
Values for the given half-times of the reactions represent averages from
at least three separate measurements. Data with two fluorescence decay
processes were fitted by the equation
Y A1  e
k1  t A2  e
k2  t
which was solved with nonlinear least-squares fitting procedures by both
the Levenberg-Marquardt algorithm and the successive integration method,
using the routines of the software provided by the instrument manufacturer.
The best-fit parameters A1 and A2 represent the amplitudes of the pro-
cesses, and k1 and k2 the respective kinetic rate constants. Representative
traces for the binding of adriamycin to phospholipid vesicles with their
respective residuals are illustrated in Fig. 1. In longer measurements (96 s)
photobleaching of pyrene due to the 450-W xenon lamp irradiation became
evident as an additional slow process. As this bleaching was very slow
(t1/2  115 s), it did not interfere with the recording of the fluorescence
intensity decays due to the membrane association of adriamycin. However,
because of the large difference in the half-times of the different compo-
nents, the routines of the software did not allow us to obtain accurate values
for relative amplitudes for the two exponential processes measured. Yet,
the relative amplitude of the fast fluorescence decay (RFI) seen within the
250-ms time domain could be obtained from the data as RFII/I0, where
I is the amplitude of the rapid fluorescence decay, and I0 is the initial
level of fluorescence of the LUVs before the rapid quenching by adriamy-
cin. The apparent rate constants (k1 and k2) obtained from the measure-
ments ranged from 0.055 to 550 s1, with the corresponding errors of
0.00045 and100 s1. These values convert to the respective half-times
of 18.18 s and 1.82 ms, with the corresponding average errors of100 and
0.8 ms (t1/2  k
1).
Importantly, although the decrease in the fluorescence intensity corre-
lates with the number of adriamycin molecules bound to the liposomes, it
is not possible to determine the actual number of drug molecules bound to
the vesicles. This is due to the fact that at low surface occupancy, the
number of donors quenched by each bound acceptor is large. However,
upon increasing surface occupancy by adriamycin, the decrement in emis-
sion intensity versus the number of additional drug molecules bound
diminishes in a progressive manner. Quantitation of resonance energy
transfer processes of this type has been shown to be inherently complex
(Drake et al., 1991). Yet, although the above drawback necessarily pre-
vents the construction of an accurate kinetic model and calculation of the
true rate constants, it does not compromise in any way the data and the
qualitative conclusions of this study.
FIGURE 1 (A) Fluorescence intensity (as photomultiplier tube output
voltages) decay after the addition of 4 M adriamycin (final concentration)
to POPC LUVs. PPDPC (X 0.03) was included in the vesicles as a donor
for resonance energy transfer. The final concentration of phospholipid was
25 M in 5 mM HEPES, 0.1 mM EDTA, pH 7.4. The cuvette was
thermostatted at 30°C. The time span of the measurement was 96 s, and a
total of 1000 spectra were recorded. (B) A representative measurement in
the 250-ms time domain and the fast fluorescence decay. The matrix lipid
was POPC with XPG  0.15, including PPDPG (X  0.03) as a fluores-
cence donor. The upper small panels show the residuals after the data were
fitted by the equation I  A  e(k1t)  B  e(k2t) (see text for further
details).
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Steady-state fluorescence measurements
DPPC:PPDPC (97:3, mol/mol) and DPPC:PPDPG (97:3, mol/mol) LUVs
for steady-state measurements were prepared as described above. The final
lipid concentration was 10 M. The fluorescence emission spectra were
recorded with a Perkin-Elmer LS50B spectrofluorometer with a magneti-
cally stirred cuvette compartment thermostatted with a circulating water
bath (WK4DS; Colora Messtechnik Gmbh, Lorch, Germany). The instru-
ment is connected to a Pentium 133-MHz PC, and the data were analyzed
with dedicated software from Perkin-Elmer. An excited-state pyrene mol-
ecule relaxes to ground state by emitting photons with a maximum at378
nm (Im) and the exact peak intensity and spectral fine structure depending
on the solvent polarity. During its lifetime, excited-state pyrene can form
a characteristic short-lived complex excimer with a ground-state pyrene.
This complex relaxes back to ground state by emitting quanta as a broad
and featureless band centered at 480 nm (Ie). In the absence of possible
quantum mechanical effects, the excimer-to-monomer ratio (Ie/Im) depends
on the rate of collisions between pyrenes. Consequently, for pyrene-
containing phospholipid analogs, the value of Ie/Im reflects the lateral
diffusion as well as the local concentration of the fluorophore in the
membrane (for a brief recent review see Kinnunen et al., 1993). The
excitation and emission bandpasses were set at 2.5 and 5 nm, respectively.
Excitation was at 344 nm, and pyrene monomer and excimer emissions
were recorded at 378 nm and 480 nm, respectively. The average
heating rate in the temperature scanning measurements was 0.1°C/min.
Differential scanning calorimetry
LUVs were prepared as above, with the exception that after extrusion the
samples were kept at 4°C overnight before the heat capacity scans were
recorded at a rate of 0.5°C/min. Gel3liquid-crystalline phase transition
temperatures of DPPC, DPPC:PPDPC (97:3, mol/mol), and DPPC:PPDPG
(97:3, mol/mol) LUVs were recorded by VP-differential scanning calorim-
etry (VP-DSC) (Microcal, Northampton, MA). This was done and the data
were analyzed using the routines of the software provided with the instru-
ment. The final lipid concentration in the DSC cuvette was 0.2 mM.
Deviation of the heat capacity from the baseline was taken as the beginning
of the transition. Likewise, the point where the enthalpy returned to the
baseline was taken as the end of the transition. The endotherms were
deconvoluted assuming the components to be Gaussian. It must be stressed,
however, that this choice for distribution profiles is arbitrary and stems
from the uncertainties regarding the detailed transition mechanisms. Yet, as
long as the latter remain poorly understood, the assumption of Gaussian
distribution is commonly used (e.g., McMullen et al., 1993). The signifi-
cance of deconvoluted DSC data must therefore be viewed with caution
and can only provide circumstantial support to results from other kinds of
measurements. Importantly, the components derived cannot be attributed to
physical processes such as phase separation or microdomains.
RESULTS
Dependence on the content of acidic
phospholipid in liposomes
Two different binding sites for adriamycin in liposomes and
the requirement for acidic phospholipid for the high-affinity
membrane association of this drug are well established
(Karczmar and Tritton, 1979; Goormagtigh et al., 1980b;
Goormaghtigh and Ruysschaert, 1984; Henry et al., 1985;
Nicolay et al., 1988; de Wolf et al., 1991; Mustonen and
Kinnunen, 1991). Accordingly, it was of interest to deter-
mine if these binding sites and the dependence on the
content of acidic phospholipids in membranes could also be
verified by kinetic measurements. For this purpose POPC
was used as a matrix while the content of POPG in the
liposomes was progressively increased. Resonance energy
transfer between pyrene emission and adriamycin absorp-
tion was utilized to monitor the membrane association of the
latter (Mustonen and Kinnunen, 1991). The measurement
temperature was 30°C, so as to have the liposomes in the
liquid-crystalline (fluid) state. For liposomes consisting of
the zwitterionic POPC and including the pyrene-derivatized
phosphatidylcholine analog PPDPC as the fluorescent donor
(XPG  0, i.e., with no net charge), the fluorescence decay
was single exponential, with a half-time of 2 s (Fig. 2 A).
As the mole fraction of PG was increased to 0.04, a second,
fast component with t1/2  2 ms became evident. The
amplitude of the fast process increased progressively as XPG
was increased to 0.25, after which saturation was reached
(Fig. 2 C). Concomitantly with the increase in the amplitude
of the fast process, the half-time of the slow process in-
creased (Fig. 2 A). Interestingly, t1/2 for the fast component
varies in a highly irregular manner as a function of XPG (Fig.
2 B). More specifically, increasing XPG from 0.05 to 0.065
causes t1/2 reach a peak. This peak in t1/2 is followed by
enhanced binding at XPG within 0.07–0.09, whereafter a
larger value for t1/2 at XPG  0.10 is again evident.
To obtain further insight into the nature of the binding
process, the content of PG in LUVs was kept constant at
XPG  0.25, and ionic strength was varied. In keeping with
an electrostatic interaction, an increase in [NaCl] up to 50
mM diminished the amplitude of the fast process, and at 100
mM NaCl this interaction was abolished completely (Fig. 3
B). The half-time of the fast process was nearly independent
of [NaCl] and varied between 2 and 4 ms (Fig. 3 A). Instead,
t1/2 for the slower component varied between 4 and 10 s,
and this decay process became faster as [NaCl] was in-
creased to 200 mM.
Ca2 ions bind to acidic phospholipids and are known to
have a strong influence on their phase behavior and orga-
nization (Galla and Sackmann, 1975; Hartmann et al., 1977;
Eklund et al., 1988, 1991). Binding of adriamycin to LUVs
(XPG  0.25) was subsequently measured at increasing
[CaCl2]. At [Ca
2] from 0 to 150 M, two-exponential
fluorescence decay was observed. The fast component had
a t1/2 between 2 and 4 ms, and it was not observed when
[Ca2] exceeded 150 M, thus lending further support to
this process being due to an electrostatic attraction. The
amplitude of the fast process as a function of [CaCl2] clearly
revealed a nonlinear dependence (data not shown). More
specifically, when [CaCl2] was increased from 0 to 25 M,
RFI decreased from 0.76 to 0.25, whereas a further increase
in [CaCl2] up to 150 M had a smaller effect, decreasing
RFI from 0.25 to 0.11. Increasing [Ca2] also caused a
minor decrease in t1/2 for the slower component, from 12 to
8 s (data not shown). The possibility that vesicle aggrega-
tion would have influenced the measured binding can be
excluded, as the threshold concentration for the Ca2-in-
duced aggregation in the literature has been observed to be
1 mM (Eklund et al., 1991), which is five times the
highest [Ca2] used in the present experiments.
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Effects of lateral heterogeneity accompanying
the main transition of DPPC/PPDPG LUVs
Exclusion of the pyrene-containing phospholipid analog,
PPDPC, from gel-state matrix consisting of DPPC has been
shown to result in the formation of microdomains enriched
in the fluorescent probe (Somerharju et al., 1985; Hresko et
al., 1986). To explore the feasibility of a similar mechanism
controlling the lateral distribution of an acidic phospholipid,
we included PPDPG at X  0.03 in a matrix of DPPC. As
shown above, with this content of the acidic phospholipid in
a fluid bilayer, only the slow binding process is observed,
i.e., the surface density of PG in LUVs is too low to yield
the fast, electrostatically driven membrane association of
adriamycin. By DSC the DPPC/PPDPG LUVs exhibited a
single endotherm with a peak centered at 40.4°C, thus
verifying that this content of PPDPG did not suffice to
abolish the main transition of DPPC (see below). In keeping
with the predicted segregation of PPDPG into microdo-
mains, the fast component in adriamycin binding was ob-
served at T 	 38°C. Likewise, above Tm  40.4°C, the fast
component was absent, thus confirming PPDPG to be ef-
fectively dispersed in the membrane so as to have the
surface negative charge density below the critical threshold
required for the fast, electrostatically driven binding of the
drug to liposomes. Interestingly, there was an intermediate
temperature range between 34 and 38.5°C, where the decay
of fluorescence was double exponential (Fig. 4 A). The
amplitude of the fast fluorescence decay (half-times ranging
between 1 and 4 ms) decreased linearly with increasing
temperature from 30 to 34°C, whereafter RFI decreased
more steeply, approaching zero at 38°C (Fig. 4 B). In-
creasing the temperature from 37 to 38.5°C prolonged t1/2
for the fast component, and at T  39°C only the slow
binding process was observed. Notably, the latter compo-
nent is due to the nonelectrostatic attraction, i.e., hydropho-
bicity. This notion is supported by measurements similar to
those above, but here the zwitterionic PPDPC instead of the
negatively charged PPDPG is used. These measurements
with the zwitterionic liposomes also confirmed that the
rapid fluorescence decay (t1/2  1–4 ms) between 30 and
38°C for the PPDPG-containing LUVs results from an
electrostatic interaction between adriamycin and the acidic
phospholipid.
fractions of the probes were XPPDPC 0.01 and XPPDPG 0.02. When XPG
was 0.03, only PPDPG was used (X  0.03). The slow component (f)
was obtained from 96-s measurements, and the fast component (F) from
250-ms measurements. The final concentration of phospholipid was 25
M, and that of adriamycin was 4 M. The temperature was 30°C. The
buffer was 5 mMHEPES, 0.1 mM EDTA, pH 7.4. Error bars indicate mean
error range for the data points and were obtained from the fitting program.
The data points shown are averages from three measurements. Please note
that the values for t1/2 are given on a logarithmic scale. B demonstrates
better the irregular dependence of t1/2 of the fast component at low XPG. (C)
The relative amplitudes of the rapid fluorescence decay as a function of XPG.
FIGURE 2 (A) The dependence of the binding of adriamycin to LUVs
on the content of acidic phospholipid. At XPG  0 the fluorescent probe
was PPDPC (X  0.03). When XPG was 0.01, the fluorescent probes were
PPDPC (X  0.02) and PPDPG (X  0.01). At XPG  0.02 the mole
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To verify changes in the lateral enrichment of the pyrene-
labeled probe into microdomains in the course of the main
transition, we then measured Ie/Im for DPPC/PPDPG alloy
as a function of temperature (Fig. 5). For DPPC/PPDPG
LUVs, values of Ie/Im increased with temperature up to
34°C, with a plateau between 34 and 37°C. Above37°C
Ie/Im begins to decrease in a progressive manner, reaching a
minimum at 41°C, after which Ie/Im in fluid-state LUVs
increases linearly as a function of temperature. For compar-
ison we also carried out the measurements under identical
conditions for the neutral pyrene-labeled probe containing
alloy, DPPC/PPDPC (Fig. 5). For the latter LUVs the Ie/Im
value increases linearly below Tm, reaching a maximum at
40°C, in accordance with previous studies (Somerharju et
al., 1985; Marcie and Lentz, 1986; Hresko et al., 1986). A
sharp decline in Ie/Im is observed at Tm with a minimum at
41°C, after which Ie/Im in the liquid crystalline state
FIGURE 3 Effect of NaCl on the kinetics of binding of adriamycin to
POPC/POPG LUVs (total XPG 0.25) with PPDPG X 0.03. (A) The fast
(F) and slow (f) components obtained from 250-ms and 96-s measure-
ments, respectively. The total lipid concentration was 25 M, and that of
adriamycin was 4 M. The temperature was 30°C; the buffer was 5 mM
HEPES, 0.1 mM EDTA, pH 7.4, with the indicated concentrations of NaCl.
Error bars are as in Fig. 2. (B) The relative amplitudes of the rapid
fluorescence decay, obtained from the same measurements as the data in A.
FIGURE 4 Dependence of the binding of adriamycin to LUVs on the
main transition of DPPC. LUVs were composed of DPPC:PPDPG (F,f)
(97:3, mol/mol). The buffer was 5 mM HEPES, 0.1 mM EDTA, pH 7.4.
The final lipid concentration was 25 M, and that of adriamycin was 4
M. The temperature was varied as indicated. For the sake of clarity, the
values for t1/2 are given on a logarithmic scale. Half-times for the compo-
nents are compiled in A, and the amplitude of the fast component of the
fluorescence decay for DPPC:PPDPG LUVs is given in B.
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increases linearly with temperature. In keeping with elec-
trostatic repulsion between the PPDPG probes augmenting
the exclusion of this substitutional impurity from the gel
state DPPC matrix and in general aiding the dispersion of
this probe, the values for Ie/Im measured for PPDPG at
temperatures above 30°C were clearly less than those for
the zwitterionic PPDPC.
To elucidate the correlation between fluorescence mea-
surements as a function of temperature and the thermally
induced main phase transition of the LUVs, used we per-
formed high-sensitivity DSC measurements for DPPC, DP-
PC:PPDPC (97:3, mol/mol), and DPPC:PPDPG (97:3, mol/
mol) LUVs (Fig. 6). The numerical data from the DSC
measurements, i.e., peak onset, offset, and maximum values
of both experimental and deconvoluted data, are compiled
in Table 1. For pure DPPC, deconvolution with one Gauss-
ian peak was not satisfactory, whereas two overlapping
Gaussian peaks yielded very good fit with the scan. For the
binary mixtures three Gaussian peaks were necessary to
reproduce the measured heat capacity scans and gave pro-
files indistinguishable from the experimental data.
DISCUSSION
Confirming the importance of electrostatic attraction be-
tween the cationic adriamycin and acidic phospholipids, the
rate of the membrane association of this drug was pro-
foundly increased upon the introduction of the negatively
charged lipid into fluid POPC LUVs. More specifically, for
POPC vesicles the half-time for fluorescence decay was 2
s, whereas as XPG was increased to 0.04-s, a fast decay
with t1/2 in the range of 2–4 ms became evident. Although
exact values cannot be calculated from the resonance energy
transfer data, this difference in the values for t1/2 readily
translates into a 1000-fold enhancement in the binding
rate in the presence of the acidic lipid. Reversal of the fast
component in the fluorescene decay by increasing [NaCl]
and [CaCl2] provides unequivocal evidence for this fast
process being mediated by electrostatic attraction. With
increasing XPG, t1/2 for the slow hydrophobic binding in-
creased from 2 s to 18 s. This is likely to reflect the decrease
in the content of adriamycin in the solution, which occurs as
a progressively larger fraction of the drug becomes rapidly
associated with liposomes by the fast electrostatic mecha-
nism. Charge neutralization in the membrane by the bound
adriamycin also readily diminishes the electrostatic attrac-
tion between the surface and the drug in the solution.
Experiments using different [Adr] demonstrated t1/2 for the
slow component to be concentration dependent, i.e., to
decrease with increasing [Adr] (data not shown). Adriamy-
cin has been shown to penetrate through the lipid bilayers
into the liposomes (Praet et al., 1993). Translocation of
adriamycin is, however, very slow, requiring 5–10 min
(Praet et al., 1993). Accordingly, it is unlikely that this
process would contribute to the fluorescence changes re-
ported here. The strong dependence of the fast electrostatic-
driven association of adriamycin on XPG allows us to use
this process to probe the initial organization of the liposome
surface prevailing before the binding of adriamycin has
commenced. At this point it is relevant to note that we did
not study the effects of adriamycin either on the membrane
organization or on the transitional behavior of the lipids.
Instead, we assessed the effects of changes in membrane
organization on the kinetics of binding of adriamycin, with
the main emphasis on the fast electrostatic association of the
drug with liposomes. More specifically, we measured the
half-times for fluorescence intensity decays due to reso-
nance energy transfer (RET), resulting from the electrostat-
ically driven membrane association of drug, as further de-
termined by the membrane content (XPG), as well as by the
initial distribution of the acidic phospholipid, PG, in the
membrane. The latter also appears to be strongly dependent
on the phase state of the DPPC matrix. After the binding
process is complete and the system has reached a new
equilibrium, the distribution of PG should be distinctly
different from that in the initial state, assessed here. Like-
wise, the phase behavior of the liposomes has been shown
to be altered by the associated drug (Goldman et al., 1978;
Constantinides et al., 1986).
An interesting feature of the dependence of t1/2 versus
XPG is that the fast component is absent when XPG 	 0.04.
This is somewhat counterintuitive, as an increase in the net
negative surface charge is readily anticipated to enhance the
rate of membrane binding of the cationic drug. Lack of the
fast decay at XPG 	 0.04 is not apparent, as the amplitude
of this process does not extrapolate to zero at XPG  0.
Likewise, equally intriguing is the highly irregular depen-
dence of t1/2 on XPG within 0 	 XPG 	 0.10, shown in Fig.
2 B. A likely explanation for the appearance of the fast
decay above XPG  0.04 could be the formation of super-
FIGURE 5 Steady-state fluorescence measurements of Ie/Im for DPPC:
PPDPG (97:3, mol/mol, f) and DPPC:PPDPC (97:3, mol/mol, E) LUVs
as a function of temperature. The total lipid concentration was 10 M in 5
mM HEPES, 0.1 mM EDTA, pH 7.4.
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lattices of the acidic phospholipid in the liquid crystalline
membranes. In brief, because of coulombic repulsion the
distribution of the deprotonated PGs can be readily expected
to have a free energy minimum when the separating dis-
tances are at maximum. This condition is fulfilled when the
acidic phospholipids are distributed as a hexagonal super-
lattice in the bilayer. As a consequence, for XPG 	 0.04 the
increase in the coulombic attraction of the drug to the
bilayer due to the acidic phospholipid would remain below
the counteracting factors, i.e., entropy and hydrophilicity of
the drug, which retard the partitioning of adriamycin into
the bilayer. However, as XPG is increased, denser superlat-
tices of PG are formed, and the magnitude of the electro-
static attraction between the drug and the membrane surface
exceeds the above energy barriers. Yet the effective net
negative surface charge density does not increase monoto-
nously with XPG, but is a step function. As a consequence,
there is a sharp threshold in XPG above which the coulombic
attraction of the drug is greatly enhanced. This is shown in
Fig. 7 A, which illustrates the regular distribution of PG at
X  0.037. At this content of PG, maximum separation of
charges is achieved when PG molecules are each separated
by five rows of phosphatidylcholine (PC). However, when
XPG exceeds 0.037, the added PG molecules must be ac-
commodated in the membrane at interstitial sites within the
original superlattice (Fig. 7 B). Accordingly, there is a sharp
local increment in net negative surface charge density. A
further increase in XPG necessitates the formation of a
denser lattice. A maximum in t1/2 is observed at XPG 
0.065. This is in accordance with a previously predicted
hexagonal superlattice (Virtanen et al., 1988) yielding the
FIGURE 6 DSC profiles (raw and deconvoluted) for the main transition
of DPPC (A), DPPC:PPDPC (97:3, mol/mol) (B), and DPPC:PPDPG (97:3,
mol/mol) (C) LUVs. The total lipid concentration was 0.2 mM in 5 mM
HEPES, 0.1 mM EDTA, pH 7.4. The measured enthalpy peaks were
deconvoluted by using either two (DPPC) or three (DPPC:PPDPC, DPPC:
PPDPG) overlapping Gaussian endotherms.
TABLE 1 Compilation of the measured and deconvoluted
DSC endotherms for the LUVs
DPPC
DPPC/PPDPC
97:3, mol/mol
DPPC/
PPDPG
97:3, mol/mol
Tm 41.2°C 40.9°C 40.4°C
T1 37.7°C 35.6°C 34.0°C
T2 43.0°C
Peak 1
Tmax 40.5°C 40.2°C 38.9°C
T1 37.7°C 36.2°C 34.0°C
T2 43.4°C 43.8°C 43.5°C
Peak 2
Tmax 41.2°C 40.9°C 40.5°C
T1 39.6°C 39.8°C 38.9°C
T2 42.8°C 42.0°C 42.0°C
Peak P
Tmax 40.3°C 40.0°C
T1 39.0°C 36.9°C
T2 41.6°C 43.3°C
Numerical data for the main transitions are those illustrated in Fig. 6. The
maximum in heat capacity in each curve is marked as Tm (experimental
data) or Tmax (in deconvoluted peaks). The deviation from the baseline is
denoted as T1 and return to the baseline as T2. The numbering of the peaks
is identical to that used in Fig. 6. See text for details.
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free energy minimum for this assembly. Importantly, for
this lattice the average charge density is smaller than in the
intermediate distribution pattern illustrated in Fig. 7 B.
Accordingly, the rate of the membrane association of adria-
mycin should decrease, as observed.
Our laboratory provided the first evidence for the forma-
tion of superlattices in fluid binary alloys (Somerharju et al.,
1985). These findings were subsequently confirmed and
extended to other compositions (e.g., Tang and Chong,
1992; Chong et al., 1994; Tang et al., 1995). Notably, these
superlattices were mainly concluded from steady-state flu-
orescence measurements, and the underlying repulsive po-
tential was suggested to be steric elastic strain imposed by
the bulky fluorescent moities. In the present case it is the
strong coulombic repulsion that provides the main driving
force. This also involves factors that complicate the predic-
tion of the exact values of XPG producing the superlattices
by the acidic headgroups, as follows. In parallel with an
increase in XPG, the affinity of the bilayer surface for
protons also increases progressively, thus decreasing the
degree of the dissociation of the phosphate moiety of PG
(Tra¨uble, 1977), with a concomitant reduction in surface
charge density. In addition, intermolecular hydrogen bond-
ing between protonated and deprotonated PG headgroups
becomes possible (Boggs, 1987), which will also necessar-
ily influence the ordering in the binary lipid alloy and
compete with the interaction of adriamycin with the depro-
tonated acidic phospholipid. The above is in keeping with
the membrane binding of another cationic ligand, cyto-
chrome c, becoming (at first glance paradoxically) slower
with increasing XPG in the liposomes (Subramanian et al.,
1998). Obviously, the above processes will also affect the
rate of binding of adriamycin to the liposomes. Accord-
ingly, particularly at higher mole fractions of PG, a more
complex dependence of t1/2 versus XPG would be expected.
We did not pursue this problem further at this stage.
The strong dependence of the fast process on XPG allowed
us to use the kinetics of the membrane association of adria-
mycin to probe changes in the lateral distribution of PG in
the course of the phospholipid main transition. Interestingly,
at T 	 34°C, only the fast binding with t1/2  4 ms was
observed (Fig. 4.), thus readily revealing the formation of
microdomains enriched in PG (i.e., with local XPG 
 0.04),
and therefore having increased negative surface density
charge. The lack of the slow hydrophobicity-driven binding
is likely to reflect the tight packing of the gel-state lipid acyl
chains, preventing the intercalation of adriamycin into the
bilayer. At T 
 34°C the slow hydrophobicity driven mem-
brane association of adriamycin also becomes evident. This
is likely to result from the formation of “fluid” domains in
the bilayer (Jutila and Kinnunen, 1997). The emergence of
“fluid” domains in gel bulk is consistent with the enhanced
hydrophobic binding of adriamycin to the electrically neu-
tral DPPC/PPDPC LUVs (containing no acidic phospho-
lipid) upon exceeding T  33°C. However, as the slow
binding process is observed for the DPPC/PPDPC LUVs
already within the temperature range of 30–33°C, it is
possible that the lack of the slow component for DPPC/
PPDPG LUVs at temperatures lower than 34°C is apparent.
More specifically, for the latter liposomes the slow compo-
nent would not be seen, as a large fraction of the drug is
already bound to the clustered acidic phospholipid, thus
reducing the concentration of adriamycin remaining in the
solution after the fast, electostatically driven membrane
association of the drug is complete. Above T  34°C the
decrease in RFI as a function of T also becomes augmented
(Fig. 4 B). In other words, although n (the number of PG
molecules encriched in clusters) diminishes when T ap-
proaches 34°C, as T exceeds this temperature, another pro-
cess causing a decrease in n becomes effective. The inter-
pretation of the appearance of the slow fluorescence decay
FIGURE 7 Schematic model of the hexagonal superlattices formed by
PG (F) in a PC (E) matrix. (A) The time-averaged organization of the
membrane at the first critical XPG, 0.037. (B) Distribution of PG upon
slightly exceeding XPG 0.037, necessitating the location of the exceeding
PGs at interstitial sites (U).
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at T  34°C as the formation of “fluid” domains in the gel
state bilayer is supported by the DSC measurements, which
revealed the onset of the main phase transition endotherm at
34°C in the DPPC/PPDPG LUVs. Simultaneously with
increasing T in the range from 34 to 38°C, the PG-enriched
clusters seem to be diminishing either in size or number as
the amplitude of the fast fluorescence decay is steeply
attenuated. Yet, although the number of PG molecules in
microdomains is decreasing, the net negative charge density
appears to reach a weak local maximum at 37°C, as
revealed by the minimum of 1 ms in t1/2.
The fast fluorescence decay for DPPC:PPDPG (97:3,
mol/mol) LUVs is not observed at T 
 37°C. This temper-
ature coincides with the plateau in Ie/Im observed in steady-
state measurements (Fig. 5), as well as with the onset of
peak P in the deconvoluted DSC data for these LUVs (Fig.
6 C and Table 1). The apparent lack of clusters of PPDPG
is revealed by the absence of the fast electrostatic compo-
nent in adriamycin binding above 37°C. This is intriguing,
as steady-state measurements still reveal highly efficient
excimer formation in the temperature range of 38–41°C
(Fig. 5). We have previously suggested PPDPC to be pref-
erentially accommodated within the interface between gel
and “fluid” domains of 1,2-myristoyl-sn-glycero-3-phos-
phocholine (DMPC) (Jutila and Kinnunen, 1997). Similar
behavior for PPDPG in the melting of DPPC matrix would
be compatible with the present data. Accordingly, the char-
acteristics of the fast component at 37°C (i.e., minimum in
both t1/2 and amplitude) would result from a change in the
dimensionality of the lateral arrangement of PPDPG from
2-D (clusters) to pseudo-1-D (arrays), the latter being
formed in the domain boundaries. For the latter, efficient
excimer formation is still evident. Importantly, small
amounts of adriamycin associated with the PPDPGs con-
centrated in these 1-D arrays residing within the domain
boundaries will strongly diminish the effective charge den-
sity and yield a small amplitude for the process, even if the
initial affinity is high. An alternative explanation is that the
size of the PPDPG clusters falls progressively with T, reach-
ing at37°C a size no longer having a sufficient number of
charges per unit surface area to provide the site for fast
binding of adriamycin. However, the latter mechanism does
not explain the fact that t1/2 has a minimum at 37°C.
Furthermore, the area of “fluid” domains at 38°C, for in-
stance, should be 75% of the total liposome surface area to
reduce the concentration of the probe XPG below 0.04 and,
accordingly, to abolish the fast binding. This seems unlikely
because the area under the nondeconvoluted endotherm up
to 38°C corresponds to only10–15% of the total enthalpy
of the transition. Accordingly, we do consider the former
mechanism to be more plausible. The driving force for the
enrichment of PPDPG into the boundaries between “fluid”
and gel domains in the temperature range of 34–38°C can
be rationalized as follows (Jutila and Kinnunen, 1997). In
brief, a perturbating substitutional impurity of PPDPG is
expelled from the gel-state DPPC matrix (Somerharju et al.,
1985; Hresko et al., 1986). Upon the transition from gel into
the liquid crystalline state, the thickness of the DPPC bi-
layers is reduced by 4.5 Å, from 23 to 18.5 Å (Chapman
et al., 1967; Lewis and Engelman, 1983). We have previ-
ously shown hydrophobic mismatch to promote the cluster-
ing of PPDPC in liquid crystalline bilayers of thickness
	20.7 Å (Lehtonen et al., 1996). The effective length of
PPDPG should equal that of PPDPC. We can thus expect
PPDPG to also be expelled to some extent from the “fluid”
domains below Tm. Accordingly, preferential partitioning of
the probe into the domain boundary can be anticipated.
CONCLUDING REMARKS
The present stopped-flow fluorescence spectroscopy mea-
surements demonstrate that the hydrophobic and electro-
static adriamycin-binding sites in liposomes can be distin-
guished by their different fluorescence decay half-times.
Subsequently, this finding was exploited to study the effect
of the DPPC main phase transition on the lateral distribution
of a trace amount of an acidic phospholipid probe PPDPG in
the bilayer. To our knowledge, this is the first observation
that the binding of a drug to a membrane can be controlled
by the formation of domains enriched in acidic phospholip-
ids and with high local negative surface charge density.
These measurements also provide evidence for the forma-
tion of “fluid” domains in the gel state matrix to begin at a
temperature well below the peak of the main transition
endotherm determined by DSC. Comparison of the stopped-
flow data with values of Ie/Im derived from steady-state
fluorescence measurements provide further evidence for the
enrichment of the fluorescent probe, PPDPG, in the inter-
face separating gel-state and fluid domains in the coexist-
ence region present in the course of the transition. These
data lend further support to our previous results indicating
the length of the interfacial boundary to have a maximum
well below the main endotherm, in this case 3.5° below
the DSC peak at 40.4°C. Accordingly, the models and
mechanisms for the phospholipid main transition may have
to be revised along the lines discussed previously (Jutila and
Kinnunen, 1997). More specifically, our fluorescence data
indicate a lack of “fluid”/gel phase boundaries in the range
from 38°C to 43.7°C. Yet, as the peak in heat capacity is
observed at 40.4°C, the molecular mechanisms underlying
the enthalpy changes in this temperature range and the
nature of the implied “intermediate” phase pose an intrigu-
ing problem. Regarding the latter, it is possible that in this
intermediate phase the chain order and lattice translational
and positional order are uncoupled, like the liquid-ordered
phase present in the phospholipid-cholesterol phase diagram
(Vist, 1984; Ipsen et al., 1987; Vist and Davis, 1990).
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